While India business disappointed, lower expenses helped margins
Experts attribute the development to rising interest for direct equity among retail investors
INEOS is the latest to see stock tank after failed move
Domestic business grew 5% in the June quarter; the fall in Africa biz was 22%
The brokerage said the decline is on account of rejig in the BSE 500 index and also due to the complete release of pledged shares in case of some companies
One in four people surveyed by Knight Frank said they were more likely to move in the next 12 months as a result of the Covid-19 pandemic
Tyagi's predecessor UK Sinha, who was initially appointed for a three-year term, was also given multiple extensions
Index is trading at 30.4 times its trailing 12-month earnings per share, highest since it began reporting its ratios in 1999
Analysts at BofA Securities have turned positive on the Indian steel sector due to higher steel prices and improving China's steel demand outlook
Share of high-margin equity is coming down in favour of less profitable liquid funds
Although Vodafone Idea Ltd. hasn't made a profit since 2017, its shares have more than doubled in the past three months
At present, an official government order allows for only 25 per cent of employees to attend work
Tyagi, a 1984 batch IAS (retired) officer of Himachal Pradesh cadre, was appointed as the Sebi chairman in March 2017 for three years
All that happened in the markets today
BSE Sensex today ended 25 points or 0.07 per cent lower at 37,663 levels while NSE's Nifty settled at 11,102, up 6 points or 0.06 per cent
The oil and gas firm posted a consolidated net profit of Rs 59.07 crore, down 74.76 per cent YoY. The net profit margin in Q1FY21, meanwhile, came in at 5.33%, clocking a de-growth of 3.43%
One in four people surveyed by Knight Frank, said they were more likely to move in the next 12 months as a result of the Covid-19 pandemic
Attractive price continued to ensure significant savings to distribution companies and industries during this time.
The stock of the pharmaceutical firm declined 4.5 per cent from its intra-day high of Rs 411.60, also its 52-week high, touched earlier in the day.
For the quarter under review, revenue from operations was up 13.44 per cent to Rs 2,713.91 crore.